65,437 trials
Meningococcal Disease · Meningococcal Meningitis
Primary: Percentage of Subjects With hSBA Titers ≥1:4 Against Meningococcal Strains, At 18 Months After Month-6 Vaccination in V72P10 Study, and in Naive Subjects. — 31; 40; 40…
Autism Spectrum Disorder
Primary: Baseline and Week 8scores on Children's Yale-Brown Obsessive Compulsive Scale - Pervasive Developmental Disorder Version — 12.7; 8.6 Scores on a scale
Cystic Fibrosis · Burkholderia Infections
Primary: AUCave of Relative Change in FEV1 % Predicted From Baseline to Week 24 — 0.16; -0.75 percent change in FEV1% predicted — p=0.663
Aortic Valve Insufficiency · Regurgitation, Aortic Valve · Aortic Valve Incompetence
Primary: Late Adverse Event Rates — 1.90; 0; 2.61; 0.12 percentage of events/late patient years
Asthma
Primary: Measurement of Change in Methacholine PC20 From Baseline Compared With Placebo 24 Hours After Dosing — 1.48; -0.2 mg/mL
Rosacea
Primary: Composite Success — 16; 10; 10; 2 participants — p=<0.001
Meningococcal Disease · Meningococcal Meningitis · Typhoid
Primary: Geometric Mean Anti-typhoid Vi Antibody Concentrations — 6.37; 5.6; 134; 153 El.U/mL
Asthma
Primary: Forced Expiratory Volume in 1 Second (FEV1) - Post Dose — 2.09; 1.97; 2.12; 2.49 Liter — p=0.001
Urostomy
Primary: Preference of Sensura vs Moderma — 45; 43 percentage of prefering the product
HIV Infection
Primary: Clinical Safety--Creatinine Elevations — 0; 0 Participants
Myopia · Hyperopia · Corneal Infiltrative Events
Primary: Number of Participants Developing a Corneal Inflammatory Event (CIE) — 6; 7 participants
Anxiety
Primary: Quality of Recovery Score — 172.8; 176.3; 174.5; 176.4 scores on a scale
Breast Cancer
Primary: Change in Mammographic Breast Density Over Course of Study — -0.5 Change in percent dense breast area
Parkinson's Disease · Motor Fluctuations
Primary: The Primary Objective of This Study is to Explore the Efficacy and Tolerability of DM-1992 Compared to a Standard CD/LD IR Formulation as Measured by Percent "OFF" Time…
Herpes Labialis
Primary: Mean Change From Baseline in Blood Flow — 2558.65; 3470.13; 809.88; 960.86 Perfusion Units — p=0.3061